- Does your PBM demonstrate every day that they put your needs and interests first, rather than prioritizing their own volume-driven profits?
- Do those other PBMs leverage clinically-driven, evidence-based data to make the right medication therapy decisions that ensure the best health outcomes for your members?
- Does your PBM focus on healthcare outcomes rather than financial arbitrage that always seems to prioritize the PBM’s profits instead of your needs and interests?
- With an estimated $863 BILLION in pharmacy spend by 2028 in the US, you need a PBM that puts you and your members’ health first.
Danny Sanchez is the Chief Executive Officer of EmpiRx Health, the leading clinically-driven pharmacy benefits management company. He is responsible for strengthening and expanding EmpiRx Health’s position as a driver of transformative change in the pharmacy benefits care industry. Danny leads the company’s mission to build and grow an innovative, high performance organization that puts the needs and interests of its customers first.
Danny’s career has been motivated by his belief that helping people access and adhere to the right therapies improves their health and impacts downstream costs. He brings 20+ years of healthcare technology experience to his role, along with a proven track record of developing and deploying innovative solutions that improve quality of care. He joined EmpiRx Health from Omnicell, where he held various leadership positions over his 16+ year tenure, and cultivated a focus on healthcare automation, patient adherence, and Population Health solutions. At Omnicell, he oversaw the launch of EnlivenHealth as General Manager, piloting numerous successful initiatives that harnessed technology to transform health and business outcomes.
His prior experience includes 3 years within the Medical Automation Division of McKesson Corporation. Danny holds degrees from Florida A&M University and from the H. Wayne Huizenga School of Business and Entrepreneurship at Nova Southeastern University.